T-bet controls intestinal mucosa immune responses via repression of type 2 innate lymphoid cell function
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 12 (1) , 51-63
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cellsNature, 2009
- The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genesProceedings of the National Academy of Sciences, 2009
- IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cellsProceedings of the National Academy of Sciences, 2009
- Dendritic cell expression of the transcription factor T-bet regulates mast cell progenitor homing to mucosal tissueJournal of Experimental Medicine, 2007
- GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factorsCell Research, 2006
- In vivo quercitrin anti‐inflammatory effect involves release of quercetin, which inhibits inflammation through down‐regulation of the NF‐κB pathwayEuropean Journal of Immunology, 2005
- T Helper Cell Fate Specified by Kinase-Mediated Interaction of T-bet with GATA-3Science, 2005
- Distinct Roles of the Phosphatidylinositol 3-Kinase and STAT5 Pathways in IL-7-Mediated Development of Human Thymocyte PrecursorsImmunity, 1999
- A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in miceGastroenterology, 1990
- Immunity to primary and challenge infections of Trichinella spiralis in mice: a re-examination of conventional parametersParasitology, 1976